Certified by Founder Lodge
Ensoma
United States - Boston, MA
START UP
1 Disclosed Funding Rounds $85,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Ensoma, we develop one-time in vivo treatments that precisely engineer any or all blood and immune cells to cure diseases from within.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| February, 06 ,2023 | Series B | $85,000,000 | |
| May, 17 ,2023 | Series B | $50,000,000.00 |
Qatar Investment Authority
Alexandria Real Estate Equities, Inc.
F-Prime Capital
Viking Global Investors
5AM Ventures
Catalio Capital Management
Arix Bioscience plc
Takeda Ventures, Inc.
Bill & Melinda Gates Foundation
Solasta Ventures
Mirae Asset Global Investments
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
